Fisher Asset Management LLC Sells 18,979 Shares of MiMedx Group, Inc. (NASDAQ:MDXG)

Fisher Asset Management LLC lowered its position in shares of MiMedx Group, Inc. (NASDAQ:MDXG) by 6.5% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 273,002 shares of the company’s stock after selling 18,979 shares during the quarter. Fisher Asset Management LLC owned approximately 0.19% of MiMedx Group worth $2,626,000 at the end of the most recent reporting period.

Several other large investors have also made changes to their positions in the company. Geode Capital Management LLC raised its holdings in MiMedx Group by 1.6% during the 3rd quarter. Geode Capital Management LLC now owns 2,794,358 shares of the company’s stock worth $16,518,000 after purchasing an additional 44,254 shares during the last quarter. Charles Schwab Investment Management Inc. raised its stake in shares of MiMedx Group by 6.9% during the third quarter. Charles Schwab Investment Management Inc. now owns 1,435,397 shares of the company’s stock worth $8,483,000 after buying an additional 92,726 shares during the last quarter. Royce & Associates LP lifted its holdings in MiMedx Group by 5.3% in the third quarter. Royce & Associates LP now owns 972,853 shares of the company’s stock valued at $5,750,000 after buying an additional 48,539 shares during the period. Bank of New York Mellon Corp boosted its stake in MiMedx Group by 0.7% in the fourth quarter. Bank of New York Mellon Corp now owns 504,007 shares of the company’s stock valued at $4,849,000 after acquiring an additional 3,300 shares during the last quarter. Finally, Disciplined Growth Investors Inc. MN grew its holdings in MiMedx Group by 0.8% during the 3rd quarter. Disciplined Growth Investors Inc. MN now owns 355,387 shares of the company’s stock worth $2,100,000 after acquiring an additional 2,737 shares during the period. Institutional investors and hedge funds own 79.15% of the company’s stock.

MiMedx Group Trading Down 0.1 %

NASDAQ MDXG opened at $8.09 on Thursday. MiMedx Group, Inc. has a one year low of $5.47 and a one year high of $10.14. The company has a debt-to-equity ratio of 0.10, a current ratio of 4.10 and a quick ratio of 3.53. The firm has a market cap of $1.19 billion, a P/E ratio of 14.71 and a beta of 1.97. The stock’s 50-day moving average is $8.66 and its 200-day moving average is $7.75.

MiMedx Group (NASDAQ:MDXG) last announced its quarterly earnings results on Wednesday, February 26th. The company reported $0.07 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.07. The firm had revenue of $92.91 million for the quarter, compared to analyst estimates of $89.42 million. MiMedx Group had a net margin of 23.86% and a return on equity of 26.21%. Sell-side analysts anticipate that MiMedx Group, Inc. will post 0.3 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several research analysts have recently issued reports on the company. StockNews.com lowered MiMedx Group from a “strong-buy” rating to a “buy” rating in a research report on Friday, November 8th. Cantor Fitzgerald restated an “overweight” rating and set a $13.00 target price on shares of MiMedx Group in a report on Thursday, February 27th. Five analysts have rated the stock with a buy rating, According to data from MarketBeat, MiMedx Group currently has an average rating of “Buy” and an average target price of $12.00.

MiMedx Group Company Profile

MiMedx Group, Inc develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue’s inherent biological properties and regulatory proteins.